Pharma: Other News To Note
Thursday, June 28, 2012
Eisai Inc., of Woodcliff Lake, N.J., said that following the approval of its first product, Zonegran (zonisamide) indicated in the treatment of epilepsy, it is expanding its operations into Russia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.